DOI QR코드

DOI QR Code

Comparative Efficacy Study of Pyeongwi-san(Pingwei-san) of Digestive Tract Disease Model in Rat

소화기 질환 동물모델에서 평위산(平胃散)의 염증 완화 효과

  • Jung, Seyoung (Department of Pathology, College of Korean Medicine, Sangji University) ;
  • Jung, Sung Eun (National Development Institute of Korean Medicine) ;
  • Kim, Ji Hye (National Development Institute of Korean Medicine) ;
  • Ham, Seong Ho (National Development Institute of Korean Medicine) ;
  • Yang, Woong Mo (Department of Convergence Korean Medical Science. College of Korean Medicine, Kyung Hee University) ;
  • Kwon, Bo-In (Department of Pathology, College of Korean Medicine, Sangji University)
  • 정세영 (상지대학교 한의과대학 병리학교실) ;
  • 정성은 (한국한의약진흥원) ;
  • 김지혜 (한국한의약진흥원) ;
  • 함성호 (한국한의약진흥원) ;
  • 양웅모 (경희대학교 한의과대학 융합한의학교실) ;
  • 권보인 (상지대학교 한의과대학 병리학교실)
  • Received : 2019.10.14
  • Accepted : 2020.03.25
  • Published : 2020.03.30

Abstract

Objectives : Pyeongwi-san is widely used in Korean medicine for acute indigestion or gastrodynia. As a therapeutic agent for digestive diseases of modern people, in order to confirm the mechanism of Pyeongwi-san on digestive tract disease and the difference of therapeutic efficacy between its formulation, a comparative efficacy test was conducted on digestive tract disease animal model. Methods : For LPS enteritis animal model, male SD rats were intraorally treated with different formulation types of Pyeongwi-san, and then intraperitoneally administered LPS one hour later to induce enteritis. After 5 hours, blood was collected and TNFα, IL-1β, IL-6 and PGE2 were confirmed by ELISA. For acute gastritis animal model, male SD rats were intraorally treated with different formulation types of Pyeongwi-san according to the prescribed concentration, and then intraorally administered 60% ethanol and 150 mM HCl one hour later to induce acute gastritis. After 5 hours, blood was collected and TNFα,IL-6 were confirmed by ELISA. Results : In the LPS-administered enteritis animal model, Pyeongwi-san decreased TNFα, IL-1β, PGE2 and especially IL-6. Pyeongwi-san also decreased IL-6 in acute gastritis animal model. In addition, there was no significant difference in efficacy between the two formulations when compared with inflammatory markers. Conclusions : The efficacy of Pyeongwi-san was confirmed in the inflammatory markers related to digestive inflammatory diseases, and the efficay between two formulations of Pyeongwi-san was relatively similar. Further studies are needed to investigate the new applicability of Pyeongwi-san on different inflammatory diseases that have similar inflammation markers identified in this experiment.

Keywords

References

  1. Huh J. Donguibogam. 1: Internal External side. 3rd rev. ed. Seoul : Yeo Gangchulpansa. 2005 ; 336-7.
  2. Hwang DH. Nephropathy bangyak happyeon. 2nd rev. ed. Seoul : Young Rimsa, 2011 ; 269-70.
  3. Ha SY. Co-relation between questionnaire for pyongwisan and physical signals. Graduate School of Kyung Hee University. 2009 ; 67.
  4. Park SH. A study on the effects of pyungweesan and compounding of medicine in pyungweesan on the movement of gastrointestinal smooth muscle, anticatharsis, and central nervous system. Graduate School of Kyung Hee University. 2000 ; 57.
  5. Lee HI. Effetcs of administration pyung yoe san to the secreting cell in the gastric mucosa of the rat. Journal of korean oriental internal medicine. 1976 ; 1(1) : 20-4.
  6. Satoh K, Nagai F, Kano I. Inhibition of H+,K+-ATPase by hinesol, a major component of so-jutsu, by interaction with enzyme in the E1 state. Biochem Pharmacol. 2000 ; 59(7) : 881-6. https://doi.org/10.1016/S0006-2952(99)00399-8
  7. Satoh K, Nagai F, Kano I. Interaction of beta-eudesmol with Na+,K(+)-ATPase: inhibition of K(+)-pNPPase activity. Biochem Pharmacol. 1992 ; 44(5) : 993-5. https://doi.org/10.1016/0006-2952(92)90134-5
  8. Seo MJ. Regulatory mechanism of IL-6 production by ${\beta}$-eudesmol, a constituent of Pyungweesan. Graduate School of Wonkwang University. 2009 ; 68.
  9. Moraes TM, Kushima H, Moleiro FC, Santos RC, Rocha LR, Marques MO, Vilegas W, Hiruma- Lima CA. Effects of limonene and essential oil from Citrus aurantium on gastric mucosa: role of prostaglandins and gastric mucus secretion. Chem Biol Interact. 2009 ; 180(3) : 499-505. https://doi.org/10.1016/j.cbi.2009.04.006
  10. Moraes TM, Rozza AL, Kushima H, Pellizzon CH, Rocha LR, Hiruma-Lima CA. Healing actions of essential oils from Citrus aurantium and d-limonene in the gastric mucosa : the roles of VEGF, PCNA, and COX-2 in cell proliferation. J Med Food. 2013 ; 16(12) : 1162-7. https://doi.org/10.1089/jmf.2012.0259
  11. Rozza AL, Moraes Tde M, Kushima H, Tanimoto A, Marques MO, Bauab TM, Hiruma-Lima CA, Pellizzon CH. Gastroprotective mechanisms of Citrus lemon (Rutaceae) essential oil and its majority compounds limonene and ${\beta}$-pinene: involvement of heat-shock protein-70, vasoactive intestinal peptide, glutathione, sulfhydryl compounds, nitric oxide and prostaglandin E. Chem Biol Interact. 2011 ; 189(1-2) : 82-9. https://doi.org/10.1016/j.cbi.2010.09.031
  12. Bonamin F, Moraes TM, Dos Santos RC, Kushima H, Faria FM, Silva MA, Junior IV, Nogueira L, Bauab TM, Souza Brito AR, da Rocha LR, Hiruma-Lima CA. The effect of a minor constituent of essential oil from Citrus aurantium: the role of ${\beta}$-myrcene in preventing peptic ulcer disease. Chem Biol Interact. 2014 ; 212 : 11-9. https://doi.org/10.1016/j.cbi.2014.01.009
  13. Sun J. D-Limonene: safety and clinical applications. Altern Med Rev. 2007 ; 12(3) : 259-64.
  14. Lee KJ, Park GY, Park GH, Liu KH, Kim TW, Ham IH, Bu YM, Choi HY. The Effects of Magnoliae officinalis Cortex and Machili thunbergii Cortex on Small Intestinal Motility. The Korea journal of herbology 2011 ; 26(4) : 75-81. https://doi.org/10.6116/KJH.2011.26.4.075
  15. Lee SR, Lee SI, Comparison of Pharmacological Effects of Magnoliae officinalis, Magnolia, and Machilus Barks. Korean Journal of Pharmacognosy. 1986 ; 17(3) : 199-205.
  16. Lee BJ, Chung MH. Studies on the Efficacy of Machili Cortex in the Digestive System. Korean Journal of Pharmacognosy. 1994 ; 25(3) : 278-92.
  17. Jeong SI, Kim YS, Lee MY, Kang JK, Lee S, Choi BK, Jung KY. Regulation of contractile activity by magnolol in the rat isolated gastrointestinal tracts. Pharmacol Res. 2009 ; 59(3) : 183-8. https://doi.org/10.1016/j.phrs.2008.11.008
  18. Hong SA, Park CW, Cho HY, Lee CW. Studies on Alkaloid of Glycyrrhiza glabra L. IV. -Anti-ulcer Activity of Licorice Alkaloid Fraction. Korean Journal of Pharmacology. 1969 ; 5(2) : 149-52.
  19. So YC, Lee SH, Choi JY, Shin EM, Kang SS, Jeong JS, Jeong CS. Antigastritic Effect of Carbenoxolone Disodium from Glycyrrhizae Radix. Journal of toxicology and public health : an official journal of the Korean Society of Toxicology. 2007 ; 23(2) : 165-72.
  20. Chen G, Zhu L, Liu Y, Zhou Q, Chen H, Yang J. Isoliquiritigenin, a flavonoid from licorice, plays a dual role in regulating gastrointestinal motility in vitro and in vivo. Phytotherapy research. 2009 ; 23(4) : 498-506. https://doi.org/10.1002/ptr.2660
  21. Kwak JS, Paek JE, Jeong SW, Kim JH, Kim JY, Kwon OR. Systematic review of the effect of dried ginger powder on improvement of nausea and vomiting associated with early pregnancy or motion sickness. Journal of nutrition and health. 2014 ; 47(1) : 45-50. https://doi.org/10.4163/jnh.2014.47.1.45
  22. Kim SJ, Kim YG, Park KY. Inhibitory Effects of Ginger and Processed (Beopje) Ginger Extracts on HCl-ethanol Induced Gastritis in Rats. Journal of the Korean society of food science and nutrition. 2012 ; 41(11) : 1528-33. https://doi.org/10.3746/jkfn.2012.41.11.1528
  23. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000 ; 84(3) : 367-71. https://doi.org/10.1093/oxfordjournals.bja.a013442
  24. Giacosa A, Morazzoni P, Bombardelli E, Riva A, Bianchi Porro G, Rondanelli M. Can nausea and vomiting be treated with ginger extract?. Eur Rev Med Pharmacol Sci. 2015 ; 19(7) : 1291-6.
  25. Saberi F, Sadat Z, Abedzadeh-Kalahroudi M, Taebi M. Effect of ginger on relieving nausea and vomiting in pregnancy: a randomized, placebocontrolled trial. Nurs Midwifery Stud. 2014 ; 3(1) : e11841.
  26. Marx W, McCarthy AL, Ried K, Vitetta L, McKavanagh D, Thomson D, Sali A, Isenring L. Can ginger ameliorate chemotherapy-induced nausea? Protocol of a randomized double blind, placebocontrolled trial. BMC Complement Altern Med. 2014 ; 14 : 134. https://doi.org/10.1186/1472-6882-14-134
  27. Marx W, Ried K, McCarthy AL, Vitetta L, Sali A, McKavanagh D, Isenring E. Ginger-Mechanism of Action in Chemotherapy-induced Nausea and Vomiting: A Review. Crit Rev Food Sci Nutr. 2017 ; 57(1) : 141-146. https://doi.org/10.1080/10408398.2013.865590
  28. Cha BC, Lee EH, Kwon JT. The Inhibitory Constituents from the Ginger on a Drug Metabolizing Enzyme CYP3A4. YAKHAK HOEJI. 2004 ; 48(5) : 266-71.
  29. Jung HK, Jang BH, Kim YH, Park JY, Park SY, Nam MH, Choi MG. Health Care Costs of Digestive Diseases in Korea. Korean J Gastroenterol. 2011 ; 58(6) : 323-31. https://doi.org/10.4166/kjg.2011.58.6.323
  30. National Health Insurance Service Health Insurance Policy Institute. 2013 Health Insurance Statistical Yearbook : 2014
  31. Ramakrishna YG, Savithri K, Kist M, Devaraj SN. Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats. BMC Complement Altern Med. 2015 ; 15 : 375. https://doi.org/10.1186/s12906-015-0915-x
  32. Bribi N, Algieri F, Rodriguez-Nogales A, Garrido-Mesa J, Vezza T, Maiza F, Utrilla MP, Rodriguez-Cabezas ME, Galvez J. Antinociceptive and Anti-Inflammatory Effects of Total Alkaloid Extract from Fumaria capreolata. Evid Based Complement Alternat Med. 2015 ; 2015 : 736895.
  33. Liu Y, Yang L, Chen KL, Zhou B, Yan H, Zhou ZG, Li Y. Knockdown of GRP78 promotes apoptosis in pancreatic acinar cells and attenuates the severity of cerulein and LPS induced pancreatic inflammation. PLoS One. 2014 ; 9(3) : e92389. https://doi.org/10.1371/journal.pone.0092389
  34. Tsutsui H, Nishiguchi S. Importance of Kupffer cells in the development of acute liver injuries in mice. Int J Mol Sci. 2014 ; 15(5) : 7711-30. https://doi.org/10.3390/ijms15057711
  35. Beynon AL, Brown MR, Wright R, Rees MI, Sheldon IM, Davies JS. Ghrelin inhibits LPSinduced release of IL-6 from mouse dopaminergic neurones. J Neuroinflammation. 2013 ; 10 : 40.
  36. Kidd M, Gustafsson BI, Drozdov I, Modlin IM. IL1beta- and LPS-induced serotonin secretion is increased in EC cells derived from Crohn's disease. Neurogastroenterol Motil. 2009 ; 21(4) : 439-50. https://doi.org/10.1111/j.1365-2982.2008.01210.x
  37. Laiakis EC, Hyduke DR, Fornace AJ. Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors ${\gamma}$ radiation and lipopolysaccharide. Radiat Res. 2012 ; 177(2) : 187-99. https://doi.org/10.1667/RR2771.1
  38. Hermann GE, Tovar CA, Rogers RC. LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol. 2002 ; 283(3) : G634-9. https://doi.org/10.1152/ajpgi.00412.2001
  39. Lee JA, Ha HK, Jung DY, Lee HY, Lee JK, Huang DS, Shin HK. Comparative Study of 25 Herbal Formulas on Anti-Inflammatory Effect. The Journal of Oriental Obstetrics & Gynecology. 2010 ; 23(3) : 101-111.
  40. Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000 ; 95(12) : 3374-82. https://doi.org/10.1111/j.1572-0241.2000.03347.x
  41. National Institute of Food and Drug Safety Evaluation. The Korean Herbal Pharmacopoeia : 2017 : 1252.
  42. Stallmach A, Strober W, MacDonald TT, Lochs H, Zeitz M. Induction and modulation of gastrointestinal inflammation. Immunol Today. 1998 ; 19(10) : 438-41. https://doi.org/10.1016/S0167-5699(98)01306-1
  43. Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clinical Reviews in Allergy & Immunology. 2005 ; 28(3) : 187-96. https://doi.org/10.1385/CRIAI:28:3:187
  44. Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol. 2014 ; 6(10) : 3.
  45. Cho MR. Targeting Interleukin-17 and Th17 in Immune Inflammatory Diseases. Hanyang Med Rev. 2013 ; 33 : 17-26. https://doi.org/10.7599/hmr.2013.33.1.17
  46. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, Aoki T, Ohnuma S, Aoki T, Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric cancer. 2005 ; 8(2) : 124-31. https://doi.org/10.1007/s10120-005-0315-x